Commentary
Medication Therapy Management Matters for Reducing Secondary Long-Term Harm from Hypertension: An important Pharmacists Role
Author(s): Maurilio De Souza Cazarim*
This is a critical analysis that had a guide the paper published in 2016 "Impact Assessment of Pharmaceutical Care in the Management of
Hypertension and Coronary Risk Factors after Discharge". In this manuscript consolidated the clinical results of the Medication Therapy
Management (MTM) in the practice of pharmaceutical care. For this it was substantiated to discussion with results of systematic reviews and
approached the evidence-based pharmacoeconomic analyses. Regarding important results increase the control of systemic blood pressure
from 54% to 93% even after three years of patient discharge. Consequently, there is a 30.3% reduction in cardiovascular risk on the
Framingham scale. The Incremental cost-effectiveness analysis ratio is US$ 605.09 in MTM period and US$ 128.03 in post-MTM period,
reaching US$ 1,725.00 and US$ 740.00 respectively. It i.. Read More»
DOI:
10.37532/dpl.2022.14.13
